10.1055/b-0035-129534 4 Hepatocellular Carcinoma: AblationRiccardo Lencioni 4.1 Introduction Hepatocellular carcinoma (HCC) is currently the second leading cause of cancer-related death worldwide. 1 Unlike most solid cancers, future incidence and mortality…
10.1055/b-0035-129536 6 Hepatocellular Carcinoma: RadioembolizationAvnesh S. Thakor, Arash Eftekhari, Edward Wolfgang Lee, Darren Klass, and David Liu 6.1 Introduction 6.1.1 Hepatocellular Carcinoma Overview Hepatocellular carcinoma (HCC) is the sixth most…
10.1055/b-0035-129539 9 Carcinoid and Neuroendocrine Tumors: Intra-arterial TherapiesElena N. Petre, Karen Brown, and Constantinos Sofocleous 9.1 Introduction Neuroendocrine tumors (NETs) are rare, typically slow-growing tumors that are frequently found only…
10.1055/b-0035-129537 7 Colorectal Hepatic Metastatic Disease: AblationMuneeb Ahmed 7.1 Introduction Percutaneous image-guided tumor ablation can be used to effectively treat hepatic metastases from primary colorectal cancer. Specific advantages of percutaneous…
10.1055/b-0035-129540 10 Cholangiocarcinoma: Ablation and Intra-arterial TherapiesMatthew Brown, Paul J. Rochon, Rajan K. Gupta, and Charles E. Ray, Jr. 10.1 Introduction Cholangiocarcinoma is an aggressive neoplasm originating from the bile…
10.1055/b-0035-129535 5 Hepatocellular Carcinoma: ChemoembolizationSiddharth A. Padia and Matthew J. Kogut 5.1 Introduction Patients with hepatocellular carcinoma (HCC) frequently present in later stages when curative treatments are no longer an…
10.1055/b-0035-129538 8 Colorectal Cancer Hepatic Metastatic Disease: Intra-arterial TherapiesGovindarajan Narayanan, and Prasoon P. Mohan 8.1 Introduction Colon cancer is the second leading cause of death from cancer in the United…
10.1055/b-0035-129532 2 Adrenal Malignancy: AblationAradhana M. Venkatesan and Bradford J. Wood 2.1 Introduction Adrenal masses are a common clinical challenge, and incidental adrenal lesions may be detected on imaging in…
10.1055/b-0035-129531 1 Percutaneous Ablation of Renal Cell CarcinomaShawn Ahmed, Raul N. Uppot, and Debra A. Gervais 1.1 Introduction Renal cell carcinoma (RCC) accounts for approximately 4% of all adult malignancies,…
10.1055/b-0038-160296 5 Chemotherapeutic AgentsDouglas M. Coldwell Abraxane, see Paclitaxel Adriamycin, see Doxorubicin Allopurinol Type: Antihyperuricemic agent. Method of action: Xanthine oxidase inhibitor. Half-life: 2 hours. Metabolized: Liver. Excretion: Feces. Indications:…
